1. Carney JA, Gordon H, Carpenter PC, Shenoy BV, Go VL 1985 The complex of myxomas, spotty pigmentation, and endocrine overactivity. Medicine (Baltimore) 64:270-283
2. Carney JA, Hruska LS, Beauchamp GD, Gordon H 1986 Dominant inheritance of the complex of myxomas, spotty pigmentation, and endocrine overactivity. Mayo Clin Proc 61:165-172
3. Bain J 1986 "Carney's complex". Mayo Clin Proc 61:508
4. Rhodes AR, Silverman RA, Harrist TJ, Perez-Atayde AR 1984 Mucocutaneous lentigines, cardiomucocutaneous myxomas, and multiple blue nevi: the "LAMB" syndrome. J Am Acad Dermatol 10:72-82
5. Atherton DJ, Pitcher DW, Wells RS, MacDonald DM 1980 A syndrome of various cutaneous pigmented lesions, myxoid neurofibromata and atrial myxoma: the NAME syndrome. Br J Dermatol 103:421-429
6. Stratakis CA, Carney JA, Lin JP, Papanicolaou DA, Karl M, Kastner DL, Pras E, Chrousos GP 1996 Carney complex, a familial multiple neoplasia and lentiginosis syndrome. Analysis of 11 kindreds and linkage to the short arm of chromosome 2. J Clin Invest 97:699-705
7. Basson CT, MacRae CA, Korf B, Merliss A 1997 Genetic heterogeneity of familial atrial myxoma syndromes (Carney complex). Am J Cardiol 79:994-995
8. Casey M, Mah C, Merliss AD, Kirschner LS, Taymans SE, Denio AE, Korf B, Irvine AD, Hughes A, Carney JA, Stratakis CA, Basson CT 1998 Identification of a novel genetic locus for familial cardiac myxomas and Carney complex. Circulation 98:2560-2566
9. Casey M, Vaughan CJ, He J, Hatcher CJ, Winter JM, Weremowicz S, Montgomery K, Kucherlapati R, Morton CC, Basson CT 2000 Mutations in the protein kinase A R1alpha regulatory subunit cause familial cardiac myxomas and Carney complex. J Clin Invest 106:R31-38
10. Kirschner LS, Carney JA, Pack SD, Taymans SE, Giatzakis C, Cho YS, Cho-Chung YS, Stratakis CA 2000 Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit in patients with the Carney complex. Nat Genet 26:89-92
11. Stratakis CA, Bertherat J, Carney JA 2004 Mutation of perinatal myosin heavy chain. N Engl J Med 351:2556-2558; author reply 2556-2558
12. Horvath A, Bertherat J, Groussin L, Guillaud-Bataille M, Tsang K, Cazabat L, Libe R, Remmers E, Rene-Corail F, Faucz FR, Clauser E, Calender A, Bertagna X, Carney JA, Stratakis CA 2010 Mutations and polymorphisms in the gene encoding regulatory subunit type 1-alpha of protein kinase A (PRKAR1A): an update. Hum Mutat 31:369-379
13. Bertherat J 2006 Carney complex (CNC). Orphanet J Rare Dis 1:21
14. Premkumar A, Stratakis CA, Shawker TH, Papanicolaou DA, Chrousos GP 1997 Testicular ultrasound in Carney complex: report of three cases. J Clin Ultrasound 25:211-214
15. Burton KA, McDermott DA, Wilkes D, Poulsen MN, Nolan MA, Goldstein M, Basson CT, McKnight GS 2006 Haploinsufficiency at the protein kinase A RI alpha gene locus leads to fertility defects in male mice and men. Mol Endocrinol 20:2504-2513
16. Stratakis CA, Kirschner LS, Carney JA 2001 Clinical and molecular features of the Carney complex: diagnostic criteria and recommendations for patient evaluation. J Clin Endocrinol Metab 86:4041-4046
17. Bertherat J, Horvath A, Groussin L, Grabar S, Boikos S, Cazabat L, Libe R, Rene-Corail F, Stergiopoulos S, Bourdeau I, Bei T, Clauser E, Calender A, Kirschner LS, Bertagna X, Carney JA, Stratakis CA 2009 Mutations in regulatory subunit type 1A of cyclic adenosine 5'-monophosphate-dependent protein kinase (PRKAR1A): phenotype analysis in 353 patients and 80 different genotypes. J Clin Endocrinol Metab 94:2085-2091
18. Scott JD 1991 Cyclic nucleotide-dependent protein kinases. Pharmacol Ther 50:123-145
19. Tasken K, Skalhegg BS, Solberg R, Andersson KB, Taylor SS, Lea T, Blomhoff HK, Jahnsen T, Hansson V 1993 Novel isozymes of cAMP-dependent protein kinase exist in human cells due to formation of RI alpha-RI beta heterodimeric complexes. J Biol Chem 268:21276-21283
20. Groussin L, Kirschner LS, Vincent-Dejean C, Perlemoine K, Jullian E, Delemer B, Zacharieva S, Pignatelli D, Carney JA, Luton JP, Bertagna X, Stratakis CA, Bertherat J 2002 Molecular analysis of the cyclic AMP-dependent protein kinase A (PKA) regulatory subunit 1A (PRKAR1A) gene in patients with Carney complex and primary pigmented nodular adrenocortical disease (PPNAD) reveals novel mutations and clues for pathophysiology: augmented PKA signaling is associated with adrenal tumorigenesis in PPNAD. Am J Hum Genet 71:1433-1442
21. Horvath A, Bossis I, Giatzakis C, Levine E, Weinberg F, Meoli E, Robinson-White A, Siegel J, Soni P, Groussin L, Matyakhina L, Verma S, Remmers E, Nesterova M, Carney JA, Bertherat J, Stratakis CA 2008 Large deletions of the PRKAR1A gene in Carney complex. Clin Cancer Res 14:388-395
22. Stergiopoulos SG, Stratakis CA 2003 Human tumors associated with Carney complex and germline PRKAR1A mutations: a protein kinase A disease! FEBS Lett 546:59-64
23. Nadella KS, Kirschner LS 2005 Disruption of protein kinase a regulation causes immortalization and dysregulation of D-type cyclins. Cancer Res 65:10307-10315
24. Mavrakis M, Lippincott-Schwartz J, Stratakis CA, Bossis I 2006 Depletion of type IA regulatory subunit (RIalpha) of protein kinase A (PKA) in mammalian cells and tissues activates mTOR and causes autophagic deficiency. Hum Mol Genet 15:2962-2971
25. Knudson AG 1996 Hereditary cancer: two hits revisited. J Cancer Res Clin Oncol 122:135-140
26. Griffin KJ, Kirschner LS, Matyakhina L, Stergiopoulos S, Robinson-White A, Weinberg F, Meoli E, Bornstein SR, Stratakis CA 2004 A mouse model for Carney complex. Endocr Res 30:903-911
27. Kirschner LS 2009 Use of mouse models to understand the molecular basis of tissue-specific tumorigenesis in the Carney complex. J Intern Med 266:60-68
28. Stratakis CA, Papageorgiou T, Premkumar A, Pack S, Kirschner LS, Taymans SE, Zhuang Z, Oelkers WH, Carney JA 2000 Ovarian lesions in Carney complex: clinical genetics and possible predisposition to malignancy. J Clin Endocrinol Metab 85:4359-4366
29. Wilkes D, McDermott DA, Basson CT 2005 Clinical phenotypes and molecular genetic mechanisms of Carney complex. Lancet Oncol 6:501-508
30. Mateus C, Palangie A, Franck N, Groussin L, Bertagna X, Avril MF, Bertherat J, Dupin N 2008 Heterogeneity of skin manifestations in patients with Carney complex. J Am Acad Dermatol 59:801-810
31. Carney JA, Stratakis CA 1998 Epithelioid blue nevus and psammomatous melanotic schwannoma: the unusual pigmented skin tumors of the Carney complex. Semin Diagn Pathol 15:216-224
32. Carney JA, Headington JT, Su WP 1986 Cutaneous myxomas. A major component of the complex of myxomas, spotty pigmentation, and endocrine overactivity. Arch Dermatol 122:790-798
33. Reynen K 1995 Cardiac myxomas. N Engl J Med 333:1610-1617
34. Lie JT 1989 The identity and histogenesis of cardiac myxomas. A controversy put to rest. Arch Pathol Lab Med 113:724-726
35. Carney JA, Toorkey BC 1991 Myxoid fibroadenoma and allied conditions (myxomatosis) of the breast. A heritable disorder with special associations including cardiac and cutaneous myxomas. Am J Surg Pathol 15:713-721
36. Carney JA, Boccon-Gibod L, Jarka DE, Tanaka Y, Swee RG, Unni KK, Stratakis CA 2001 Osteochondromyxoma of bone: a congenital tumor associated with lentigines and other unusual disorders. Am J Surg Pathol 25:164-176
37. Pavel E, Nadella K, Towns WH, 2nd, Kirschner LS 2008 Mutation of Prkar1a causes osteoblast neoplasia driven by dysregulation of protein kinase A. Mol Endocrinol 22:430-440
38. Stratakis CA, Carney JA, Kirschner LS, Willenberg HS, Brauer S, Ehrhart-Bornstein M, Bornstein SR 1999 Synaptophysin immunoreactivity in primary pigmented nodular adrenocortical disease: neuroendocrine properties of tumors associated with Carney complex. J Clin Endocrinol Metab 84:1122-1128
39. Tsigos C, Papanicolaou DA, Chrousos GP 1995 Advances in the diagnosis and treatment of Cushing's syndrome. Baillieres Clin Endocrinol Metab 9:315-336
40. Gunther DF, Bourdeau I, Matyakhina L, Cassarino D, Kleiner DE, Griffin K, Courkoutsakis N, Abu-Asab M, Tsokos M, Keil M, Carney JA, Stratakis CA 2004 Cyclical Cushing syndrome presenting in infancy: an early form of primary pigmented nodular adrenocortical disease, or a new entity? J Clin Endocrinol Metab 89:3173-3182
41. Stratakis CA, Sarlis N, Kirschner LS, Carney JA, Doppman JL, Nieman LK, Chrousos GP, Papanicolaou DA 1999 Paradoxical response to dexamethasone in the diagnosis of primary pigmented nodular adrenocortical disease. Ann Intern Med 131:585-591
42. Raff SB, Carney JA, Krugman D, Doppman JL, Stratakis CA 2000 Prolactin secretion abnormalities in patients with the "syndrome of spotty skin pigmentation, myxomas, endocrine overactivity and schwannomas" (Carney complex). J Pediatr Endocrinol Metab 13:373-379
43. Pack SD, Kirschner LS, Pak E, Zhuang Z, Carney JA, Stratakis CA 2000 Genetic and histologic studies of somatomammotropic pituitary tumors in patients with the "complex of spotty skin pigmentation, myxomas, endocrine overactivity and schwannomas" (Carney complex). J Clin Endocrinol Metab 85:3860-3865
44. Yin Z, Williams-Simons L, Parlow AF, Asa S, Kirschner LS 2008 Pituitary-specific knockout of the Carney complex gene Prkar1a leads to pituitary tumorigenesis. Mol Endocrinol 22:380-387
45. Stratakis CA, Courcoutsakis NA, Abati A, Filie A, Doppman JL, Carney JA, Shawker T 1997 Thyroid gland abnormalities in patients with the syndrome of spotty skin pigmentation, myxomas, endocrine overactivity, and schwannomas (Carney complex). J Clin Endocrinol Metab 82:2037-2043
46. Shawker TH, Doppman JL, Choyke PL, Feuerstein IM, Nieman LK 1992 Intratesticular masses associated with abnormally functioning adrenal glands. J Clin Ultrasound 20:51-58
47. Carney JA 1990 Psammomatous melanotic schwannoma. A distinctive, heritable tumor with special associations, including cardiac myxoma and the Cushing syndrome. Am J Surg Pathol 14:206-222
48. Watson JC, Stratakis CA, Bryant-Greenwood PK, Koch CA, Kirschner LS, Nguyen T, Carney JA, Oldfield EH 2000 Neurosurgical implications of Carney complex. J Neurosurg 92:413-418
49. Carney JA, Toorkey BC 1991 Ductal adenoma of the breast with tubular features. A probable component of the complex of myxomas, spotty pigmentation, endocrine overactivity, and schwannomas. Am J Surg Pathol 15:722-731
50. Cignarelli M, Picca G, Campo M, Margaglione M, Marino A, Logoluso F, Giorgino F 2005 A six month mitotane course induced sustained correction of hypercortisolism in a young woman with PPNAD and Carney complex. J Endocrinol Invest 28:54-60
51. Brown B, Ram A, Clayton P, Humphrey G 2007 Conservative management of bilateral Sertoli cell tumors of the testicle in association with the Carney complex: a case report. J Pediatr Surg 42:E13-15
52. Horvath A, Giatzakis C, Robinson-White A, Boikos S, Levine E, Griffin K, Stein E, Kamvissi V, Soni P, Bossis I, de Herder W, Carney JA, Bertherat J, Gregersen PK, Remmers EF, Stratakis CA 2006 Adrenal hyperplasia and adenomas are associated with inhibition of phosphodiesterase 11A in carriers of PDE11A sequence variants that are frequent in the population. Cancer Res 66:11571-11575
53. Robinson-White AJ, Bossis I, Hsiao HP, Nesterova M, Leitner WW, Stratakis CA 2009 8-Cl-adenosine inhibits proliferation and causes apoptosis in B-lymphocytes via protein kinase A-dependent and independent effects: implications for treatment of Carney complex-associated tumors. J Clin Endocrinol Metab 94:4061-4069